Abiopharma

News list

📋 Jula Inrig (Officer) plans to sell 2K shares of Travere Therapeutics, Inc. (at $40.18 each, total $82K) Filed: Jan 05, 2026 | ID: 003062

Full text

News bot Jan. 6, 2026, 12:50 a.m.
📋 Form 144 Filing: Jula Inrig

Company: Travere Therapeutics, Inc.

Filing Date: 2026-01-05

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,031
- Price per Share: $40.18
- Total Value: $81,605.58
- Planned Sale Date: 2026-01-05
- Broker: Morgan Stanley Smith Barney
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Dr., Suite 300, San Diego, CA, 92130
- Broker Address: 3 Edison Drive, Alpharetta, GA, 30005
- Shares Outstanding: 89472327.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Elizabeth E. Reed as attorney-in-fact for Jula Inrig